Pulmonary function and adrenal gland suppression with incremental doses ofaerosolized beclomethasone dipropionate in horses with recurrent airway obstruction
Br. Rush et al., Pulmonary function and adrenal gland suppression with incremental doses ofaerosolized beclomethasone dipropionate in horses with recurrent airway obstruction, J AM VET ME, 217(3), 2000, pp. 359-364
Citations number
27
Categorie Soggetti
Veterinary Medicine/Animal Health
Journal title
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
Objective-To evaluate clinical response, pulmonary function, and adrenal gl
and response to incremental doses of beclomethasone dipropionate in horses
with recurrent airway obstruction.
Design-Crossover trial.
Animals-8 horses with recurrent airway obstruction.
Procedure-Horses randomly assigned to 4 groups were treated twice daily via
aerosol administration of placebo or 500, 1,000, or 1,500 mu g of beclomet
hasone dipropionate in a crossover design with a 10-day minimum washout per
iod. Subjective assessment of airway obstruction, serum cortisol concentrat
ion, and maximum change in pleural pressure during tidal breathing (Delta P
pl(max)) were determined daily prior to morning drug administration, and De
lta Ppl(max) was reevaluated 15 minutes after morning drug administration.
Pulmonary resistance and dynamic compliance were determined at baseline and
approximately 12 hours after the final treatment.
Results-An immediate treatment effect was not identified. Within 24 hours,
Delta Ppl(max) and airway obstruction were lower in horses receiving beclom
ethasone. Onset and magnitude of response was similar among the 3 beclometh
asone dose regimens. Pulmonary resistance was improved only after administr
ation of all 3 doses of beclomethasone, whereas dynamic compliance was impr
oved after administration of 1,000 mu g and 1,500 mu g of beclomethasone. R
eduction in serum cortisol concentration occurred with all 3 beclomethasone
dose regimens; however, the magnitude of adrenal gland suppression was gre
ater in horses receiving 1,000 or 1,500 mu g of beclomethasone.
Conclusions and Clinical Relevance-Low-dose (500 mu g) beclomethasone admin
istration caused similar improvement in pulmonary function, compared with h
igh-dose beclomethasone (1,000 and 1,500 mu g), with the exception of dynam
ic compliance, and caused less suppression of endogenous cortisol productio
n.